Sun Pharma Advanced Research Company Ltd.

BSE: 532872 | NSE: SPARC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE232I01014 | SECTOR: Biotechnology & Medical ResearchBiotechnology & Medical Research

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharma Adv Sun Pharma Advanced Research Company Ltd. | BSE 134.90 -2.15 (-1.57%) | NSE 135.19 -1.76 (-1.29%) | Trade | Add

BSE Live

Oct 31, 16:01

134.90 -2.15 (-1.57%)

Volume

AVERAGE VOLUME

5-Day

163,506

10-Day

90,854

30-Day

47,911

19,891

Prev. Close

137.05
Open Price

136.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 31, 15:59

135.19 -1.76 (-1.29%)

Volume

AVERAGE VOLUME

5-Day

1,827,641

10-Day

997,995

30-Day

520,847

198,988

Prev. Close

136.95
Open Price

136.09

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
135.19 (1878)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Sun Pharma Advanced Research Company (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	-10.64	-11.96	-7.82	-7.73	-5.77
Diluted EPS (Rs.)	-10.64	-11.96	-7.82	7.73	-5.77
Cash EPS (Rs.)	-10.30	-11.59	-6.50	-7.11	-5.35
Book Value [ExclRevalReserve]/Share (Rs.)	-6.80	3.85	15.80	1.15	-6.42
Book Value [InclRevalReserve]/Share (Rs.)	-6.80	3.85	15.80	1.15	-6.42
Dividend / Share(Rs.)	0.00	0.00	0.00	0.00	0.00
Revenue from Operations/Share (Rs.)	2.21	2.33	7.36	5.05	9.65
PBDIT/Share (Rs.)	-10.03	-11.53	-6.26	-6.62	-4.94
PBIT/Share (Rs.)	-10.36	-11.91	-6.62	-6.99	-5.36
PBT/Share (Rs.)	-10.64	-11.96	-6.86	-7.48	-5.77
Net Profit/Share (Rs.)	-10.64	-11.96	-6.86	-7.48	-5.77
Profitability Ratios
PBDIT Margin (%)	-453.53	-495.49	-85.09	-131.07	-51.22
PBIT Margin (%)	-468.62	-511.54	-90.01	-138.48	-55.53
PBT Margin (%)	-481.03	-513.73	-93.21	-148.19	-59.74
Net Profit Margin (%)	-481.03	-513.73	-93.21	-148.19	-59.74
Return on Networth / Equity (%)	0.00	-310.83	-43.40	-651.37	0.00
Return on Capital Employed (%)	756.68	-159.39	-33.00	-174.92	3,836.49
Return on Assets (%)	-104.84	-79.80	-26.81	-72.61	-65.80
Total Debt/Equity (X)	-1.17	0.38	0.00	2.40	-1.17
Asset Turnover Ratio (%)	0.18	0.11	0.43	0.54	110.12
Liquidity Ratios
Current Ratio (X)	0.07	1.01	2.54	0.42	0.27
Quick Ratio (X)	0.07	1.01	2.54	0.42	0.27
Inventory Turnover Ratio (X)	0.00	0.00	0.00	0.00	0.00
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	0.00
Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Valuation Ratios
Enterprise Value (Cr.)	5,060.04	11,897.92	5,712.17	8,144.74	3,900.74
EV/Net Operating Revenue (X)	70.51	157.49	23.92	59.34	15.42
EV/EBITDA (X)	-15.55	-31.79	-28.11	-45.27	-30.11
MarketCap/Net Operating Revenue (X)	66.93	158.92	24.39	58.81	14.68
Retention Ratios (%)	0.00	0.00	0.00	0.00	0.00
Price/BV (X)	-21.77	96.16	11.36	258.49	-22.07
Price/Net Operating Revenue	66.93	158.93	24.39	58.81	14.68
Earnings Yield	-0.07	-0.03	-0.04	-0.03	-0.04